{"id":"W4220971510","doi":"10.1002/ajh.26536","title":"Health‐related quality of life in patients with <scp>light chain</scp> amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the <scp>ANDROMEDA</scp> study","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Statistics Canada; Alberta Health Services","funders":"Janssen Research and Development","keywords":"Medicine; Andromeda; Daratumumab; Internal medicine; Bortezomib; Population; Amyloidosis; Cyclophosphamide; Oncology; Multiple myeloma; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001819681,0.0003353727,0.0007632683,0.0001828383,0.0001855307,0.00050836,0.0002214054,0.0003382852,0.0004496944],"category_scores_gemma":[0.001075853,0.0001470332,0.001151566,0.0003079359,0.0002323242,0.000298532,0.0002504204,0.0007132055,0.00009989183],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002919373,"about_ca_system_score_gemma":0.0003932084,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000474431,"about_ca_topic_score_gemma":0.000873012,"domain_scores_codex":[0.9994198,0.0003432042,0.00004854107,0.0000565728,0.00007892666,0.00005311766],"domain_scores_gemma":[0.9991596,0.000212602,0.0003212801,0.00005129545,0.00005183719,0.0002034413],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1760509,0.009920288,0.6619397,0.000592988,0.005124621,0.000197249,0.0003918961,0.003638816,0.01243875,0.0001324724,0.001610513,0.1279617],"study_design_scores_gemma":[0.0264526,0.07664203,0.8886811,0.0000612331,0.001446485,0.0003457218,0.00009914065,0.002694528,0.00182795,0.0001877178,0.00152781,0.00003367189],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984871,0.0008904723,0.00008157188,0.00006018383,0.0000113865,0.0000513186,0.000151526,0.000003883275,0.0002624773],"genre_scores_gemma":[0.9990579,0.0002106591,0.0001844867,0.0001012858,0.00002153408,0.00005344522,0.0002723096,0.000001039884,0.00009731673],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001819681,"threshold_uncertainty_score":0.009623528,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008644266222533767,"score_gpt":0.2469216453471016,"score_spread":0.2382773791245679,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}